Lou Conley

NASA Advances Research In Human Hibernation For Mars Journey NASA is exploring ways to induce a hibernation-like state in humans often called synthetic torpor or quasi-torpor to help astronauts endure the challenges of long-duration missions to Mars and beyond. A crewed trip to Mars could take 6–9 months one way, with total mission durations stretching into years. During such voyages, crews face significant risks including space radiation, muscle and bone loss from microgravity, psychological stress from isolation and confinement, and the enormous logistical burden of carrying food, water, oxygen, and other supplies. Inducing a reduced-metabolic state could dramatically lower these demands by slowing the body’s need for resources while potentially offering protective effects against some hazards. Recent progress includes NASA-funded human research at the University of Pittsburgh. In studies supported through the Translational Research Institute for Space Health (TRISH), healthy volunteers received controlled doses of the sedative dexmedetomidine (an alpha-2 adrenergic agonist) to achieve a safe, reversible reduction in metabolic rate (around 20%) and slight lowering of core body temperature. Participants entered a groggy, sleep-like state but remained capable of waking for short periods to eat, drink, or use the restroom—avoiding the need for full sedation or life-support interventions. This “quasi-torpor” approach represents a practical first step toward mimicking key benefits of natural hibernation. Complementary NASA efforts focus on animal models. The STASH (Studying Torpor in Animals for Space-health in Humans) project, selected under the 2024 NASA Innovative Advanced Concepts (NIAC) program, proposes a specialized laboratory for the International Space Station to study torpor in rodents under microgravity conditions for the first time. Goals include understanding how hibernation-like states affect bone and muscle preservation and testing methods to induce or mimic synthetic torpor. Long-term vision: human applications that could mitigate multiple risks of deep-space travel. Earlier conceptual work, such as NASA-funded studies on torpor-inducing transfer habitats, has shown that placing crews in a reduced-metabolic state could significantly shrink spacecraft mass and consumables requirements. Research on hibernating animals like Arctic ground squirrels funded in part by NASA has also provided insights into how extreme metabolic suppression can preserve muscle and bone mass, offering lessons potentially transferable to space medicine and even terrestrial critical care. While full synthetic hibernation for astronauts remains a long-term goal requiring extensive further testing for safety and efficacy, these incremental steps—combining pharmacology, cooling techniques, and fundamental biology—are building the scientific foundation. Success could make ambitious missions to Mars and beyond more feasible, safer, and resource-efficient. This area of research continues to evolve through partnerships between NASA, universities, and institutes focused on space health.